Samil Pharmaceutical Co.,Ltd (000520.KS) KSC

Currency In KRW

AD

Valuation

Market Cap205.88B
Enterprise Value363.49B
P/E Ratio-3.97
PEG Ratio0.05
Price/Sales Ratio0.69
Price/Book Ratio1.12
Enterprise/Revenue1.47
Enterprise/EBITDA-24.28

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.17
Operating Margin-0.13
AD

Management Effectiveness

Return On Assets-0.1
Return On Equity-0.26

Income Statement

Revenue210.37B
Revenue/Share9,897.47
Gross Profit67.44B
EBITDA-10.72B
Net Income-34.59B
Diluted EPS-1,627.95

Balance Sheet

Total Cash1.19B
Total Cash/Share55.82
Total Debt166.03B
Total Debt/Equity1.29
Current Ratio0.46
Book Value Per Share6,040.88

Price History

52-Week Change-32.57
52-Week High12,860
52-Week Low6,620
Moving Average 50 Days8,422.6
Moving Average 200 Days9,750.95

Statistics

Average Volume219,956
Shares Outstanding21.37M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor11:10
Last Split DateMarch 24, 2023
AD